Artificial Intelligence (AI) In MRI Market Size, Share, Opportunities, And Trends By Solution (Software, Services), By End-User (Hospitals, Clinics, Diagnostic Centers), And By Geography - Forecasts From 2025 To 2030

The artificial intelligence (AI) in the MRI market is projected to grow at a CAGR of 18.07% over the forecast period, increasing from US$1.061 billion in 2025 to US$2.435 billion by 2030.

MRI or magnetic resonance imaging is a type of non-invasive medical imaging solution, which helps in detecting various types of internal structures. In MRI technology, the integration of artificial intelligence helps in enhancing the maximum potential of the MRI technology. The AI in the MRI helps in enhancing the efficiencies of the imaging solution, and it also increases the potential of detecting diseases more accurately.

The increasing technological advancements in the healthcare sector are expected to boost the demand for AI technology in the MRI market. The AI technology witnessed massive growth, majorly with the increasing governmental initiatives across multiple nations to integrate the technology in the healthcare sector.

What are the Artificial Intelligence (AI) in MRI Market drivers?

• The growing prevalence of cancer is driving the market growth globally.

The rising global cases of cancers and other forms of chronic diseases are also expected to propel the growth of AI in the MRI market, during the forecasted timeline. For instance, according to the American Cancer Society, Inc. in its 2023 Cancer report stated that in the USA, the total estimated new cases of cancer were recorded at 1.958 million, with about 1.010 million new cases recorded in males, and 0.948 million cases recorded in females.

As per the American Heart Association, Inc, Cardiovascular mortality in the United States has risen to 931,578 in 2024 from 928,741 in 2023. It breaks down into deaths from coronary heart disease (40.3%), stroke (17.5%), other minor CVD causes (17.1%), high blood pressure (13.4%), heart failure (9.1%), and artery diseases (2.6%).

Another growing trend is patient comfort and access to care as improving scan time with less discomfort and personalized care as other driving factors for AI based MRI software. Demands for client-centric software systems that improve MRI scan precision, efficiency, and accessibility propel this trend.

MRI Software Using AI Technology is poised to grow concerning innovations in point-of-care imaging, workflow optimization, and improving images with more AI-powered denoising techniques for diverse MRI sequences, as well as the advent of even smaller and easily portable AI-powered imaging in the future.

Hyperfine, Inc. announced the introduction of the eighth-generation software of the Swoop® system, approved by CE and UKCA in January 2024. The software includes improved image quality and convenience and is being launched at selected sites. The DWI AI denoising feature gained FDA clearance in October 2023. This software extends real-time assistance for more accurate loading and patient positioning, along with a more streamlined image upload procedure. Swoop® is revolutionizing the neuroimaging workflow by bringing brain imaging to the point of the patient's bedside rather than expensive, statically deployed MRI technology.

The growing use of MRI scans generates a significant amount of data, which can be challenging for human radiologists to efficiently analyze. AI algorithms can quickly process and provide valuable insights.

Segment analysis of AI in MRI Market:

• By solution, the software segment will account for a considerable market share. 

The MRI software segment is driven by the growing adoption of AI to increase diagnostic accuracy, efficiency, and improved image quality. AI can process MRI images more accurately than human radiologists, hence, making a diagnosis earlier stage of disease progression for cancers, neurological disorders, and cardiovascular diseases.  AI software is designed to automate regular tasks that would increase the productivity of radiologists whose time can be spent working on complex cases. This allows shorter turnaround time for the patient.

• Hospitals, based on end-user will account for a considerable market share. 

An AI-powered MRI assures better accuracy and efficiency in the imaging services of hospitals, thus meeting the growing demand for quality patient care. AI complements the entire treatment plan by providing accurate estimates for disease progression and its consequent outcome predictions. This assists not only in improving patient care but also enhances the quality of life.

Routine task automation and enhanced efficiency provided by AI in MRI systems in imaging services can greatly reduce cost incidences for hospitals.  In the U.S. healthcare spending statistics, the overall total in 2022 dedicated to health reportedly stood at $4.5 trillion, or $13,493 per capita. And from this spending, hospital care accounted for the biggest share at 30.4%, amounting to $1,355 billion in 2022, as per American Medical Association data.

Market players heavily rely on AI and deep learning algorithms to improve image quality and precision in MRI technology. In addition, such technological advancement in MRI will fundamentally transform hospital services towards better efficiency, patient experience, democratic access, and personalized care in an overall better patient experience. In November 2023, GE HealthCare launched one of the world's most advanced AI-enhanced 1.5T wide-bore MRIs called the SIGNA Champion. At the March 2023 Annual Meeting of the Radiological Society of North America, GE HealthCare announced the system as part of examining it under the auspices of personalization for the care associated with better MRI exam democratization through faster, more precise scans enabled by access to advanced AI and innovative features.

Hospitals are the major users of AI-enabled MRI technology, with the growing need for high-quality imaging services propelling them forward. AI-powered MRI could prove to be a boost for these facilities, as it would make their services much more accurate and efficient, thus relieving some of the pressure they face concerning providing care for their patients.

What are the key geographical trends shaping the AI in the MRI Market:

• North America will continue to hold a remarkable share of the market during the forecast period.

Artificial Intelligence has established a framework of exploring new opportunities of the modern technology applicability in varied healthcare fields, that would optime the diagnosis and treatment process. The United States stands at the forefront of adopting such latest innovations. According to the research study issued by Oxford Scholars, in which nearly 5,920 hospitals across 50 US states were surveyed. It was noted that 18.70% or 1,107 hospitals adopted some form of Artificial Intelligence by 2022, and hospitals in major states namely New Jersey held the highest adoption rate of 48.94%.

 The rise in the demand for effective treatment and precise diagnosis has garnered a wide customer base for advanced technologies which has positively impacted the scope of AI usage in MRI applications. This growing prevalence of chronic disease especially cardiac-related is posing a challenge for US healthcare professionals to leverage a proprietary technology that would target the breakthroughs in treatment and offer high-quality diagnostic MRI. Hence major companies are investing in strategic partnerships and research collaboration to meet this demand. For instance, on 3rd December 2024, Mayo Clinic formed a research collaboration with Philips that aimed to optimize the latter’s technical with Mayo’s healthcare expertise which will harness the Artificial Intelligence usage in advanced MRI for cardiac applications.

AI In MRI Market Scope:

Report Metric	Details
AI In MRI Market Size in 2025	US$1.061 billion
AI In MRI Market Size in 2030	US$2.435 billion
Growth Rate	CAGR of 18.07%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Solution End-User Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in AI In MRI Market	Siemens Healthineers AG GE HealthCare IBM Philips Healthcare NVIDIA Corporation
Customization Scope	Free report customization with purchase

 

AI in MRI market is analyzed into the following segments:

• By Solution
  • Software
  • Services
• By End-User
  • Hospitals
  • Clinics
  • Diagnostic Centers
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Singapore
    • Indonesia
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Process

2.3. Data Validation

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Supplier

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. ARTIFICIAL INTELLIGENCE (AI) IN MRI MARKET BY SOLUTION

5.1. Introduction

5.2. Software

5.3. Services

6. ARTIFICIAL INTELLIGENCE (AI) IN MRI MARKET BY END-USER

6.1. Introduction

6.2. Hospitals

6.3. Clinics

6.4. Diagnostic Centers

7. ARTIFICIAL INTELLIGENCE (AI) IN MRI MARKET BY GEOGRAPHY

7.1. Introduction

7.2. North America

7.2.1. By Type

7.2.2. By Industry Vertical

7.2.3. By Country

7.2.3.1. USA

7.2.3.2. Canada

7.2.3.3. Mexico

7.3. South America

7.3.1. By Type

7.3.2. By Industry Vertical

7.3.3. By Country

7.3.3.1. Brazil

7.3.3.2. Argentina

7.3.3.3. Others

7.4. Europe

7.4.1. By Type

7.4.2. By Industry Vertical

7.4.3. By Country

7.4.3.1. United Kingdom 7.4.3.2. Germany

7.4.3.3.  France

7.4.3.4. Spain

7.4.3.5. Others

7.5. Middle East and Africa

7.5.1. By Type

7.5.2. By Industry Vertical

7.5.3. By Country

7.5.3.1. Saudi Arabia

7.5.3.2. UAE

7.5.3.3. Others 

7.6. Asia Pacific

7.6.1. By Type

7.6.2. By Industry Vertical

7.6.3. By Country

7.6.3.1. China

7.6.3.2. Japan

7.6.3.3. India 

7.6.3.4. South Korea

7.6.3.5. Australia

7.6.3.6. Singapore

7.6.3.7. Indonesia 

7.6.3.8. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Competitive Dashboard

9. COMPANY PROFILES

9.1. Siemens Healthineers AG

9.2. GE HealthCare

9.3. IBM

9.4. Philips Healthcare

9.5. NVIDIA Corporation

9.6. Oxipit.ai

9.7. Quibim

9.8. Intel

9.9. AWS

9.10. Google Cloud

9.11. Aikenist Technologies Pvt. Ltd.

9.12. CARPL.ai

9.13. Subtle Medical, Inc.

Siemens Healthineers AG

GE HealthCare

IBM

Philips Healthcare

NVIDIA Corporation

Oxipit.ai

Quibim

Intel

AWS

Google Cloud

Aikenist Technologies Pvt. Ltd.

CARPL.ai

Subtle Medical, Inc.